Halozyme Therapeutics (HALO) market cap

Market cap today
$10.94B

Halozyme Therapeutics (HALO) has a market cap of $10.94B. At the end of fiscal 2025 (December 31, 2025) its market cap was $8.34B. That is 34.8% higher than the $6.19B of fiscal 2024. Today's figure is 31.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 09:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$10.94B
Market cap, fiscal 2025
$8.34B
Change on fiscal 2024
+34.8%
Growth, 5 years
+6.7% a year
Growth, 10 years
+14.3% a year
Highest on record
$8.34Bfiscal 2025
Lowest on record
$1.26Bfiscal 2016
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Halozyme Therapeutics market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 6.7% a year; over ten years the rate was 14.3% a year. Across the 11 fiscal year-ends on record (2015–2025), the highest was $8.34B in fiscal 2025 and the lowest $1.26B in fiscal 2016.

History · 11 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Halozyme Therapeutics market cap, year by year

Halozyme Therapeutics (HALO) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$10.94B—$95.97—
2025$8.34B 34.8% up$67.30123.90M
2024$6.19B 24.8% up$47.81129.42M
2023$4.96B 38.0% down$36.96134.20M
2022$8.00B 35.5% up$56.90140.61M
2021$5.90B 2.3% down$40.21146.80M
2020$6.04B 136.1% up$42.71141.46M
2019$2.56B 21.8% up$17.73144.33M
2018$2.10B 25.4% down$14.63143.60M
2017$2.82B 122.9% up$20.26139.07M
2016$1.26B 42.4% down$9.88127.96M
2015$2.20B—$17.33126.70M
2014——$9.65—
2013——$14.99—
2012——$6.71—
2011——$9.51—
2010——$7.92—
2009——$5.87—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Halozyme Therapeutics and comparable companies
CompanyMarket cap
Fresenius Medical Care FMS$11.26B
Kymera Therapeutics KYMR$10.37B
DaVita DVA$10.88B
Halozyme Therapeutics HALO$10.94B
Universal Health Services UHS$11.07B
Repligen RGEN$10.37B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on HALO

Halozyme Therapeutics, figure by figure

Halozyme Therapeutics (HALO) overview: price, valuation and scorecardAll health care companies by market value

Halozyme Therapeutics market cap: questions and answers

What is Halozyme Therapeutics's market cap?

Halozyme Therapeutics (HALO) has a market cap of $10.94B. At the end of fiscal 2025 (December 31, 2025) its market cap was $8.34B. That is 34.8% higher than the $6.19B of fiscal 2024.

What is the growth rate of Halozyme Therapeutics's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 6.7% a year; over ten years the rate was 14.3% a year.

What are the highest and lowest market cap figures on record for Halozyme Therapeutics?

Across the 11 fiscal year-ends on record (2015–2025), the highest was $8.34B in fiscal 2025 and the lowest $1.26B in fiscal 2016.

How is Halozyme Therapeutics's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Halozyme Therapeutics it is on record here for 11 fiscal years, 2015 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Halozyme Therapeutics (HALO) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/HALO/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.